DK2681192T3 - Synthesis of 2-carboxamide-cycloamino-urea derivatives - Google Patents

Synthesis of 2-carboxamide-cycloamino-urea derivatives Download PDF

Info

Publication number
DK2681192T3
DK2681192T3 DK12706843.5T DK12706843T DK2681192T3 DK 2681192 T3 DK2681192 T3 DK 2681192T3 DK 12706843 T DK12706843 T DK 12706843T DK 2681192 T3 DK2681192 T3 DK 2681192T3
Authority
DK
Denmark
Prior art keywords
formula
compound
solvent
solvents
base
Prior art date
Application number
DK12706843.5T
Other languages
Danish (da)
English (en)
Inventor
Bernhard Erb
Isabelle Sylvie Gallou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2681192(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK2681192T3 publication Critical patent/DK2681192T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK12706843.5T 2011-03-03 2012-03-01 Synthesis of 2-carboxamide-cycloamino-urea derivatives DK2681192T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (1)

Publication Number Publication Date
DK2681192T3 true DK2681192T3 (en) 2018-04-16

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12706843.5T DK2681192T3 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide-cycloamino-urea derivatives

Country Status (33)

Country Link
US (3) US9650373B2 (https=)
EP (1) EP2681192B1 (https=)
JP (1) JP6022485B2 (https=)
KR (1) KR101851421B1 (https=)
CN (2) CN103402982B (https=)
AR (2) AR088714A1 (https=)
AU (1) AU2012222346B2 (https=)
BR (1) BR112013021882A2 (https=)
CA (1) CA2828509C (https=)
CL (1) CL2013002521A1 (https=)
CO (1) CO6751286A2 (https=)
DK (1) DK2681192T3 (https=)
EA (4) EA025381B1 (https=)
EC (1) ECSP13012914A (https=)
ES (1) ES2663717T3 (https=)
GT (1) GT201300211A (https=)
HU (1) HUE036319T2 (https=)
IL (1) IL228023A (https=)
MA (1) MA34982B1 (https=)
MX (2) MX351740B (https=)
MY (1) MY163214A (https=)
NO (1) NO2681192T3 (https=)
PE (1) PE20140917A1 (https=)
PH (1) PH12013501796A1 (https=)
PL (1) PL2681192T3 (https=)
PT (1) PT2681192T (https=)
SG (1) SG192793A1 (https=)
SI (1) SI2681192T1 (https=)
TN (1) TN2013000354A1 (https=)
TW (2) TWI597279B (https=)
UA (1) UA112539C2 (https=)
WO (1) WO2012117071A1 (https=)
ZA (1) ZA201306174B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
DE60023926T2 (de) 1999-09-10 2006-07-20 Merck & Co., Inc. Tyrosin kinase inhibitoren
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
CA2639910A1 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2240475B1 (en) * 2007-12-20 2013-09-25 Novartis AG Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
PH12013501796A1 (en) 2022-10-26
CA2828509C (en) 2018-11-20
KR20140009432A (ko) 2014-01-22
JP6022485B2 (ja) 2016-11-09
EA032802B1 (ru) 2019-07-31
NO2681192T3 (https=) 2018-05-26
IL228023A (en) 2017-04-30
TW201247660A (en) 2012-12-01
TWI597279B (zh) 2017-09-01
CA2828509A1 (en) 2012-09-07
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
EA201691331A1 (ru) 2017-01-30
BR112013021882A2 (pt) 2016-07-19
EP2681192B1 (en) 2017-12-27
US20170240509A1 (en) 2017-08-24
EP2681192A1 (en) 2014-01-08
MX2013010132A (es) 2013-10-30
ZA201306174B (en) 2014-05-28
ES2663717T3 (es) 2018-04-16
CN106083840B (zh) 2020-01-03
CN103402982B (zh) 2016-07-13
AR123584A2 (es) 2022-12-21
PT2681192T (pt) 2018-04-02
NZ614173A (en) 2015-04-24
US20170355677A1 (en) 2017-12-14
MA34982B1 (fr) 2014-03-01
EA201892052A1 (ru) 2019-02-28
SI2681192T1 (en) 2018-04-30
UA112539C2 (uk) 2016-09-26
US20130331579A1 (en) 2013-12-12
MX351740B (es) 2017-10-26
CN103402982A (zh) 2013-11-20
AU2012222346B2 (en) 2015-05-07
ECSP13012914A (es) 2013-11-29
SG192793A1 (en) 2013-09-30
US9650373B2 (en) 2017-05-16
PE20140917A1 (es) 2014-08-14
GT201300211A (es) 2014-12-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
TW201722916A (zh) 2017-07-01
US10059670B2 (en) 2018-08-28
AR088714A1 (es) 2014-07-02
TN2013000354A1 (en) 2015-01-20
EA201391267A1 (ru) 2014-01-30
WO2012117071A1 (en) 2012-09-07
CL2013002521A1 (es) 2014-02-14
EA201792068A2 (ru) 2018-01-31
TWI607994B (zh) 2017-12-11
CN106083840A (zh) 2016-11-09
CO6751286A2 (es) 2013-09-16
EA025381B1 (ru) 2016-12-30
IL228023A0 (en) 2013-09-30
EA201792068A3 (ru) 2018-05-31
KR101851421B1 (ko) 2018-04-23
HUE036319T2 (hu) 2018-06-28
JP2014511387A (ja) 2014-05-15
US9776966B2 (en) 2017-10-03

Similar Documents

Publication Publication Date Title
DK2681192T3 (en) Synthesis of 2-carboxamide-cycloamino-urea derivatives
CN101346357B (zh) 氨基二氢噻嗪衍生物
CA3154942A1 (en) Small molecule degraders of helios and methods of use
KR20100098534A (ko) 바이러스 폴리머라제 억제제
CN105198821A (zh) 洛昔替尼的制备方法
JP6594351B2 (ja) 新規中間体を含むアルキル化アリールピペラジン及びアルキル化アリールピペリジン化合物の製造方法
EP3444244A1 (en) Preparation process for high-purity dabigatran etexilate
CN116783167A (zh) 新颖吖啶鎓盐及其制造方法
CN105315268A (zh) 一种利伐沙班有关物质、其中间体、制备方法和用途
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
NZ614173B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
KR102221534B1 (ko) 치환된 감마 락탐의 합성을 위한 공정
WO2016023522A2 (en) Substituted phosphoramidate compounds and uses thereof
HK40023056A (en) Process for the synthesis of substituted gamma lactams
CA3002920A1 (en) Method for removing dimethoxybenzyl group
ITMI20070942A1 (it) Processo per la preparazione di imatinib e suoi intermedi
WO2015180593A1 (zh) 具有抗病毒活性的苯并杂环己二烯衍生物